Works matching DE "RESPIRATORY syncytial virus infection vaccines"
Results: 222
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 97, doi. 10.3390/vaccines13020097
- By:
- Publication type:
- Article
Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 97, doi. 10.3390/vaccines13020097
- By:
- Publication type:
- Article
Preventing RSV Infection in Children: Current Passive Immunizations and Vaccine Development.
- Published in:
- Pathogens, 2025, v. 14, n. 2, p. 104, doi. 10.3390/pathogens14020104
- By:
- Publication type:
- Article
Burden and Economic Impact of Respiratory Viral Infections in Adults Aged 60 and Older: A Focus on RSV.
- Published in:
- Diseases, 2025, v. 13, n. 2, p. 35, doi. 10.3390/diseases13020035
- By:
- Publication type:
- Article
More than Baby Steps: Preventing Respiratory Syncytial Virus in Infants.
- Published in:
- touchREVIEWS in Infectious Diseases, 2024, v. 3, n. 1, p. 11, doi. 10.17925/ID.2024.3.1.4
- By:
- Publication type:
- Article
Author Correction: An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
An epitope-specific chemically defined nanoparticle vaccine for respiratory syncytial virus.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00347-y
- By:
- Publication type:
- Article
Microfluidic qPCR for detection of 21 common respiratory viruses in children with influenza-like illness.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79407-x
- By:
- Publication type:
- Article
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults.
- Published in:
- Clinical & Experimental Immunology, 2023, v. 211, n. 3, p. 269, doi. 10.1093/cei/uxad003
- By:
- Publication type:
- Article
The Cumulative Variations of Respiratory Syncytial Virus Fusion Protein (F) in Ten Consecutive Years in China.
- Published in:
- Infectious Disease Reports, 2024, v. 16, n. 5, p. 1017, doi. 10.3390/idr16050081
- By:
- Publication type:
- Article
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy.
- Published in:
- Infectious Disease Reports, 2024, v. 16, n. 1, p. 128, doi. 10.3390/idr16010010
- By:
- Publication type:
- Article
More Protection Against Respiratory Viral Infection: Respiratory Syncytial Virus Vaccines for Adults Aged 60 Years and Older.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 10, p. 1419, doi. 10.7326/M23-2196
- By:
- Publication type:
- Article
Annals for Educators - October 2023.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 10, p. 1, doi. 10.7326/AWED202310170
- By:
- Publication type:
- Article
Residency in Long-Term Care Facilities: An Important Risk Factor for Respiratory Syncytial Virus Hospitalization.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 5, p. e1007, doi. 10.1093/infdis/jiae424
- By:
- Publication type:
- Article
Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 5, p. e996, doi. 10.1093/infdis/jiae316
- By:
- Publication type:
- Article
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 3, p. e647, doi. 10.1093/infdis/jiae081
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 3, p. e637, doi. 10.1093/infdis/jiae035
- By:
- Publication type:
- Article
Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion Maternal Vaccine Coadministered With Diphtheria-Tetanus-Pertussis Vaccine: A Phase 2 Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e353, doi. 10.1093/infdis/jiad560
- By:
- Publication type:
- Article
The Annual Economic Burden of Respiratory Syncytial Virus in Adults in the United States.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. e342, doi. 10.1093/infdis/jiad559
- By:
- Publication type:
- Article
Respiratory Syncytial Virus–Associated Hospitalization in Adults With Comorbidities in 2 European Countries: A Modeling Study.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, p. S70, doi. 10.1093/infdis/jiad510
- By:
- Publication type:
- Article
Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, p. S51, doi. 10.1093/infdis/jiad449
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intranasal respiratory syncytial virus vaccine attenuated by codon-pair deoptimization of seven open reading frames is genetically stable and elicits mucosal and systemic immunity and protection against challenge virus replication in hamsters.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 5, p. 1, doi. 10.1371/journal.ppat.1012198
- By:
- Publication type:
- Article
Assessing the burden of respiratory syncytial virus disease in Australia.
- Published in:
- Medical Journal of Australia, 2019, v. 210, n. 10, p. 444, doi. 10.5694/mja2.50173
- By:
- Publication type:
- Article
Protecting pregnant women and their newborn from life‐threatening infections.
- Published in:
- Medical Journal of Australia, 2019, v. 210, n. 10, p. 445, doi. 10.5694/mja2.50174
- By:
- Publication type:
- Article
COVID-19 Associated with Higher Long-Term Mortality Than Flu or RSV: New Data.
- Published in:
- Patient Care (Online), 2025, p. 3
- By:
- Publication type:
- Article
RSVPreF Reduces Risk of Severe RSV in Older, High-Risk Adults in Large Real-World Study.
- Published in:
- Patient Care (Online), 2025, p. 12
- By:
- Publication type:
- Article
FDA Updates RSV Vaccine Labels to Include Guillain-Barré Syndrome Warning.
- Published in:
- Patient Care (Online), 2025, p. 4
- By:
- Publication type:
- Article
US Adults Lagging in Flu, COVID-19, and RSV Vaccination: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 12
- By:
- Publication type:
- Article
A Vaccination Imperative: "Please, Let's Do It," NFID Medical Director Robert Hopkins, Jr, MD, Urges.
- Published in:
- Patient Care (Online), 2024, p. 14
- By:
- Publication type:
- Article
Safety of Moderna's mRNA RSV Vaccine for Infants Heads Dec 12 VRBPAC Meeting Agenda.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Flu, COVID-19, RSV Vaccine Uptake Low Among US Adults in 2024-2025 Season.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare: Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare: Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
The RSV Vaccine Population was Narrowed for Good Reason, says Robert Hopkins, Jr, MD, Medical Director of the NFID: ACIP recommendations for the most appropriate older population for the RSV vaccine has shifted and the NFID medical director explains why.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
FDA Expands Indication for RSV Vaccine Abrysvo to Include Adults Aged 18 to 59 with Chronic Conditions.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
New Data Highlight Social, Racial Disparities in Flu, COVID-19, RSV Vaccine Uptake.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
New Data for Arexvy Show Vaccine Efficacy Through 3 RSV Seasons in Older Adults.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Mortality Higher than for Influenza B 90 Days After Hospital Discharge: New Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
RSV Vaccine Effective Against Hospitalization in Older Adults: Daily Dose.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Co-administration of Arexvy and Shingrix Yields Positive Topline Phase 3 Data, GSK Reports.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
RSV Vaccine Proves 75% Effective Against Hospitalization in Older Adults, According to New CDC Data.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations.
- Published in:
- Patient Care (Online), 2024, p. 69
- By:
- Publication type:
- Article
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data.
- Published in:
- Patient Care (Online), 2024, p. 50
- By:
- Publication type:
- Article
ACIP Revises Recommendation for Adult RSV Vaccination.
- Published in:
- Patient Care (Online), 2024, p. 22
- By:
- Publication type:
- Article
ACIP Recommendations for RSV Vaccines in Older Adults: Update August 2024.
- Published in:
- Patient Care (Online), 2024, p. 25
- Publication type:
- Article